Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Significant peri-operative reduction in plasma osteopontin levels after coronary artery by-pass grafting.

Sbarouni E, Georgiadou P, Mihas C, Chaidaroglou A, Degiannis D, Voudris V.

Clin Biochem. 2012 Nov;45(16-17):1513-5. doi: 10.1016/j.clinbiochem.2012.04.019.

PMID:
22580396
2.

Increased ischaemia modified albumin following coronary artery bypass grafting.

Sbarouni E, Georgiadou P, Panagiotakos D, Alivizatos PA, Voudris V.

Biomarkers. 2009 Feb;14(1):38-42. doi: 10.1080/13547500902730706.

PMID:
19283522
3.

Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myoglobin release.

Chowdhury UK, Malik V, Yadav R, Seth S, Ramakrishnan L, Kalaivani M, Reddy SM, Subramaniam GK, Govindappa R, Kakani M.

J Thorac Cardiovasc Surg. 2008 May;135(5):1110-9, 1119.e1-10. doi: 10.1016/j.jtcvs.2007.12.029.

4.

Long-term prognostic value of cardiac troponin I and T versus creatine kinase-MB mass after cardiac surgery in low-risk patients with stable symptoms.

Vikenes K, Andersen KS, Melberg T, Farstad M, Nordrehaug JE.

Am J Cardiol. 2010 Sep 15;106(6):780-6. doi: 10.1016/j.amjcard.2010.04.038.

PMID:
20816117
5.
6.

C-reactive protein and coronary artery disease.

Auer J, Berent R, Lassnig E, Eber B.

Jpn Heart J. 2002 Nov;43(6):607-19.

7.

A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery.

Januzzi JL, Lewandrowski K, MacGillivray TE, Newell JB, Kathiresan S, Servoss SJ, Lee-Lewandrowski E.

J Am Coll Cardiol. 2002 May 1;39(9):1518-23.

8.

Pre-operative high sensitive C-reactive protein predicts cardiovascular events after coronary artery bypass grafting surgery: a prospective observational study.

Balciunas M, Bagdonaite L, Samalavicius R, Griskevicius L, Vuylsteke A.

Ann Card Anaesth. 2009 Jul-Dec;12(2):127-32. doi: 10.4103/0971-9784.53442.

9.
10.

Plasma osteopontin as a predictor of coronary artery disease: association with echocardiographic characteristics of atherosclerosis.

Abdel-Azeez HA, Al-Zaky M.

J Clin Lab Anal. 2010;24(3):201-6. doi: 10.1002/jcla.20378.

PMID:
20486203
11.

The increased plasma C-reactive protein and interleukin-6 levels in patients undergoing coronary artery bypass grafting surgery are associated with the interleukin-6-174G > C gene polymorphism.

Wypasek E, Undas A, Sniezek-Maciejewska M, Kapelak B, Plicner D, Stepien E, Sadowski J.

Ann Clin Biochem. 2010 Jul;47(Pt 4):343-9. doi: 10.1258/acb.2010.090305.

PMID:
20592333
12.

Prognostic significance of plasma osteopontin levels in patients undergoing percutaneous coronary intervention.

Kato R, Momiyama Y, Ohmori R, Tanaka N, Taniguchi H, Arakawa K, Nakamura H, Ohsuzu F.

Circ J. 2009 Jan;73(1):152-7.

13.

Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients.

Kaireviciute D, Blann AD, Balakrishnan B, Lane DA, Patel JV, Uzdavinys G, Norkunas G, Kalinauskas G, Sirvydis V, Aidietis A, Lip GY.

Thromb Haemost. 2010 Jul;104(1):122-7. doi: 10.1160/TH09-12-0837.

PMID:
20458440
14.

Postoperative levels of cardiac troponin versus CK-MB and high-sensitivity C-reactive protein for the prediction of 1-year cardiovascular outcome in patients undergoing vascular surgery.

Kouvelos GN, Milionis HJ, Arnaoutoglou EM, Chasiotis G, Gartzonika C, Papa NK, Tzimas P, Matsagkas MI.

Coron Artery Dis. 2011;22(6):428-34. doi: 10.1097/MCA.0b013e3283487d96.

PMID:
21730823
15.

Release of cardiac biochemical and inflammatory markers in patients on cardiopulmonary bypass undergoing coronary artery bypass grafting.

Meng QH, Zhu S, Sohn N, Mycyk T, Shaw SA, Dalshaug G, Krahn J.

J Card Surg. 2008 Nov-Dec;23(6):681-7. doi: 10.1111/j.1540-8191.2008.00701.x.

PMID:
18778302
16.

Osteopontin in relation to Prognosis following Coronary Artery Bypass Graft Surgery.

Sbarouni E, Georgiadou P, Chatzikyriakou S, Analitis A, Chaidaroglou A, Degiannis D, Voudris V.

Dis Markers. 2016;2016:1868739. doi: 10.1155/2016/1868739.

17.

Osteopontin protects against cardiac ischemia-reperfusion injury through late preconditioning.

Wang Y, Chen B, Shen D, Xue S.

Heart Vessels. 2009 Mar;24(2):116-23. doi: 10.1007/s00380-008-1094-1.

PMID:
19337795
19.

Serum neopterin and activity of coronary artery disease.

Auer J, Berent R, Labetanig E, Eber B.

Heart Dis. 2001 Sep-Oct;3(5):297-301.

PMID:
11975809
20.

Supplemental Content

Support Center